Skip to main content

regulatory_update

NPC Calls for National Program to Map US Subsurface Resources

NPC Calls for National Program to Map US Subsurface Resources

WASHINGTON – September 03, 2026 -- The National Petroleum Council (NPC) has issued nine recommendations urging Congress and federal agencies to launch a coordinated national program to assess America's subsurface energy and mineral resources, warning that over 80% of the country's energy needs depend on assets that remain largely unmapped for decades.

The report, titled "American Resources for a Secure Future: A National Cooperative Subsurface Assessment Program," was commissioned by U.S. Secretary of Energy Chris Wright and developed by roughly 80 experts spanning state government, Tribal organizations, industry, and academia. It was approved by a full vote of NPC membership.

IDEAYA Sets Phase 3 Design for IDE849 After FDA Type C Meeting

IDEAYA Sets Phase 3 Design for IDE849 After FDA Type C Meeting

SOUTH SAN FRANCISCO, Calif. -- September 01, 2026 -- IDEAYA Biosciences said its FDA Type C meeting on IDE849, a DLL3-targeting antibody drug conjugate, produced agreement on a Phase 3 registrational trial design for extensive stage small cell lung cancer (ES-SCLC). The Nasdaq-listed company (IDYA) plans to enroll roughly 400 patients who have already received tarlatamab, randomizing them 1:1 between IDE849 monotherapy and an investigator's choice control arm of topotecan and amrubicin. IDEAYA is targeting trial initiation by year-end 2026.